MediView XR is a Cleveland, Ohio med-tech company building augmented-reality 'X-ray vision' for surgeons. Founded in 2017 on Cleveland Clinic intellectual property, MediView's FDA-cleared XR90 platform and OmnifyXR Interventional Suite let clinicians see a patient's 3D anatomy - bone, tissue, organs, and vasculature - holographically projected through the skin during minimally invasive, ultrasound-guided procedures. Backed by GE HealthCare, Mayo Clinic, and Cleveland Clinic, the company raised a $24M Series A in October 2025.
Nob Hill Therapeutics is an Albuquerque, New Mexico respiratory healthcare company re-envisioning inhalation medicines. Its patented DryNeb dry powder nebulizer is designed to deliver high doses of medicine directly to the lungs while a patient breathes normally, combining the strengths of dry powder inhalers and liquid nebulizers. Spun out of VIC Technology Venture Development and based on the Lovelace Respiratory Research Institute campus, the company is targeting hard-to-treat lung diseases such as lower respiratory tract infections, lung fungal infections and lung cancer.
Noyo is a San Francisco-based benefits data platform that uses APIs and AI to connect insurance carriers, benefits administration software, and HR teams. It turns the slow, error-prone exchange of employee benefits data into real-time, automated connections, eliminating manual data entry and coverage-impacting errors across the benefits ecosystem.
SurgiQuality is a Rockville, Maryland health-tech company built by a practicing surgeon to fix the information gap patients face when they are told they need an operation. Its platform brings medical records and imaging to the cloud, routes them to a network of 45,000+ surgeons for independent written opinions, and uses proprietary AI (SurgiGPT) to score surgeons on risk-adjusted outcomes pulled from de-identified EMR data. The goal: help patients pick the right surgeon and the right approach, avoid unnecessary surgery, and help employers lower the cost of surgical benefits.
Pedro Coelho is the founder and CEO of Biorce, a Barcelona-based health AI company building software that designs and manages clinical trials in minutes instead of months. A Portuguese entrepreneur with over eight years in life sciences consulting, he started Biorce after a clinical trial bought his father, who was dying of melanoma, ten extra months of life. In February 2026 the company closed a $52M Series A led by DST Global, the largest Series A in Iberian healthtech and AI, backed by angels including the CEOs of Mistral, Revolut, OutSystems and Seedtag.
Pedro Sanchez de Lozada is the founder and CEO of Canid, a New York healthtech company that takes the operational, financial, and data drudgery of running a vaccine program off pediatricians' plates. A Chilean who has spent more than 15 years building software for small businesses (Udemy, Rinse, Merlin), he started Canid in 2020 after managing his pediatrician relatives' practices during the Covid-19 pandemic. In 2025 Canid raised a $10M Series A led by Telescope Partners, bringing total funding to $12.9M, while serving 150+ independent pediatricians across 12 states.
Richard Fine is Chief Business Officer at Zocdoc, where for more than a decade he has helped turn a doctor-booking marketplace into what he calls 'healthcare access infrastructure.' A two-time founder with two exits, he built Help Remedies, the over-the-counter brand that made aspirin boxes funny and won a Cannes Lion, and spent years as a brand strategist at Redscout working with Nike, PepsiCo and Diageo. Oxford-trained in Philosophy, Politics and Economics and raised by two epidemiology professors, he frames his work simply: he loves healthcare and hates its incentives, and at Zocdoc he gets to fix both.
Robby Knight is the co-founder and CEO of evermore (formerly Soda Health), a healthtech company that turns supplemental health benefits into a Smart Benefits platform connecting Medicare Advantage members, health plans, and retailers like CVS, Walgreens, and Kroger. A social worker by training who spent nearly eight years architecting consumer health at Walmart, Knight built the company on a simple frustration: people's first-order needs (food, OTC medicine, transportation) were being met through a patchwork of inefficient programs. evermore has raised roughly $100 million, including a $50M Series B led by General Catalyst in December 2024.
Robin Berzin is the founder and CEO of Parsley Health, a holistic, root-cause medical practice she launched in 2016 to make functional medicine modern, data-driven, and reachable online nationwide. A Columbia-trained physician who started out chasing securities fraud as a paralegal at the U.S. Attorney's office, she co-founded the doctor-messaging app Cureatr in medical school before building Parsley into one of the largest functional medicine practices in the country. She is the author of State Change, a World Economic Forum Tech Pioneer, and one of Inc.'s 100 most innovative women in business.
Shahrukh Chaudhary is the founder of Onora AI, a Milton, Ontario startup building an AI-powered virtual front desk for dental clinics and DSOs across North America. His agents answer after-hours calls, book and reschedule appointments against live availability, run insurance checks, and chase down no-shows - taking clinics from 10 to 15 missed calls a night to zero. Before dentistry, he spent 15-plus years scaling tech businesses, including running Careem's Karachi operations and building products at Azul Code and Hoid.pk.
Avant-garde Health is a Boston-based healthcare data analytics company whose CareMeasurement platform helps hospitals, ambulatory surgery centers and physicians measure the true cost, quality and processes of surgical care - then turn those insights into measurable savings and better patient outcomes. Founded in 2014 out of value-based care research at Harvard Business School, the company applies Time-Driven Activity-Based Costing (TDABC) across EMR, financial, claims and patient-reported outcomes data to reveal what was previously invisible inside the operating room and the care pathway around it.
Clairity is a Boston-based healthtech company that built Clairity Breast, the first FDA-authorized AI platform that predicts a woman's five-year risk of breast cancer directly from a routine screening mammogram. Founded by Harvard radiologist Dr. Connie Lehman, the company turns images already sitting in the medical record into a forward-looking risk score, aiming to move breast care from late-stage detection toward early, equitable prevention.
Luminopia is a commercial-stage digital therapeutics company that turns a child's favorite TV shows into FDA-cleared medicine for amblyopia (lazy eye). Children wear a VR headset for one hour a day, six days a week, and watch curated, real-time-modified episodes that retrain the brain to use both eyes together. Founded by Harvard dropouts and incubated at Boston Children's Hospital, Luminopia One became the first FDA-approved digital therapeutic for a neuro-visual disorder.
Medisafe is a digital health company that turns the everyday struggle of taking pills on time into a behavior-driven engagement platform. Born from a near-fatal insulin overdose in the founders' own family, it began as a free virtual pillbox app and grew into an enterprise platform - anchored by Medisafe Maestro and its Just-in-Time Interventions (JITI) engine - that pharmaceutical companies use to keep patients on therapy. With more than 13 million users worldwide and 4+ billion doses tracked, Medisafe sits at the intersection of consumer mobile health and the multibillion-dollar problem of medication non-adherence.
SuperDial is a San Francisco voice AI company that builds agents to handle the endless administrative phone calls between healthcare providers, billing companies and insurers - navigating phone trees, waiting on hold, and conducting live conversations with payer reps. Its agents automate benefits verification, prior authorizations, claim status follow-up, credentialing and provider data attestation, logging structured results directly into a customer's EHR or RCM platform. Founded by Stanford classmates Sam Schwager and Harrison Caruthers (originally as the billing startup SuperBill), the company launched in late 2023, scaled to seven-figure revenue and tens of thousands of calls per week, and raised a $15M Series A in June 2025 led by SignalFire.
Tomorrow Health is a New York-based health technology company that connects providers, payors, and durable medical equipment (DME) suppliers on a single platform so home-based care can be ordered, routed, and paid for without the usual paperwork chaos. Founded by Vijay Kedar and Casper co-founder Gabriel Flateman, it uses intelligent automation - and, increasingly, AI - to turn a process that historically took hours of faxes and phone calls into something closer to a clean digital order, serving more than 100 health plans and managing over $100 million in DME spend.
Sam Holliday is the co-founder and CEO of Oshi Health, the first nationwide virtual GI center of excellence, built on value-based, whole-person care. A digital health operator since 2013, he scaled companies across diabetes management, patient acquisition and population health before launching Oshi in 2019. In October 2024 the company raised a $60M Series C led by Oak HC/FT, reaching all 50 states and more than 40 million in-network members.
Shimin Ooi is the CEO of Sleep Reset, a virtual sleep clinic that pairs licensed clinical care with a proprietary CBT-I program to treat insomnia without sleeping pills. A Princeton graduate who built her career across McKinsey, Pilot, and Index Ventures, she now runs a company arguing that a lot of what people call burnout is really untreated bad sleep. In 2025 she took Sleep Reset's pitch to the HLTH stage and walked away with the AARP AgeTech After Dark prize.
William G. Hendren, MD, MBA is the co-founder and CEO of QURA, Inc., a Duxbury, Massachusetts medical technology company building the QSmart platform - an implantable biosensor roughly the size of a grain of rice that continuously measures and wirelessly transmits medical-grade blood pressure data in real time. A surgeon trained at Harvard, Mass General, Emory and the Cleveland Clinic, with an MBA and strategic healthcare consulting experience at PwC across the US, Middle East, China and the UK, Hendren is taking aim at hypertension, which he calls the single leading healthcare threat in the world.
Yoona Kim is the co-founder and CEO of Arine, a San Francisco medication intelligence company she started in 2017 with CTO Penjit 'Boom' Moorhead. A pharmacist and health economist by training, Kim built Arine to attack one of medicine's least glamorous and most expensive problems: people getting the wrong drugs, the wrong doses, and the wrong combinations. Arine's AI platform now touches more than 25 million lives across 40-plus health plan clients, and the company says its work has cut hospitalizations by over 40% for clients while shaving care costs by double digits.
Carl Madi is the co-founder and CEO of Stepful, a New York healthtech and edtech company that trains people for allied healthcare careers in weeks instead of years. After scaling operations at Uber, Airbnb, Handy, and Amino Apps and earning an MBA from Wharton, he started Stepful in 2021 with Tressia Hobeika and Edoardo Serra. The company runs AI-assisted, cohort-based programs for medical assistants, pharmacy techs, and other frontline roles, places graduates through a network of 8,000+ clinical partners, and was ranked the #1 EdTech company in the U.S. by TIME in 2025.
Dave Icke is the CEO of Medisafe, the medication engagement platform that helps more than ten million patients stay on their treatments. A chemical engineer turned digital-health operator, he has spent two decades turning hardware and software into tools that keep people healthier: founding CEO of wearable biosensor company mc10, launcher of Becton Dickinson's digital health business, VP of Digital Health Product at Humana, and executive chair of mental-health AI company ieso. In 2025 he took the reins at Medisafe from founder Omri Shor to scale medication engagement across the global pharmaceutical ecosystem.
Derek Haas is the founder and CEO of Avant-garde Health, a Boston healthtech company that helps hospitals and surgeons see the true cost and quality of the care they deliver. He calls himself the black sheep of a family full of doctors. Instead of practicing medicine, he turned Harvard Business School research with professors Michael Porter and Bob Kaplan into a company that put a price tag and an outcome score on every surgical episode. He has co-authored nine Harvard Business Review articles and built a software platform, CareMeasurement, that now spans surgical and procedure-based care.
Elizabeth Burstein is the CEO and co-founder of Neura Health, a virtual neurology clinic she started in 2020 after a two-year fight with a trapped nerve exposed how broken specialist access is in the United States. A Stanford computer-science-and-philosophy grad who built product at LinkedIn, Blue Apron, Zocdoc and Maven Clinic before turning founder, she has grown Neura to serve tens of thousands of patients and raised $22M+ in venture funding, including a $11.4M Series A in 2025 led by the American Heart Association's Go Red for Women Venture Fund.
Gavin Cotter is the founder and CEO of Koala Health, a Boston-based digital pet pharmacy that delivers chronic pet medications through a mobile-first platform built to work directly with pet parents and their veterinarians. An MIT-trained mechanical engineer turned operations leader, he cut his teeth scaling PillPack's pharmacy operations before Amazon acquired it, then reassembled a core PillPack crew in 2021 to do for animals what PillPack did for people: make managing medications boring, easy, and reliable. Koala has since expanded to all 50 states and raised a $20M Series B led by Valspring Capital in 2025.
James Jiang is the cofounder and CEO of Spark, a New York company building the technology and back-office services that independent Medicare brokers use to run their businesses. A Yale graduate who started as a global technology investor and then cofounded the in-home senior care company Roster Health, he bet that the future of Medicare belongs to local independent agents rather than call centers or private-equity roll-ups. Under his lead, Spark raised a $25M Series B in 2024 and processed roughly 250,000 enrollments across 10,000 agents in 2025.
John Voith is the CEO and co-founder of InStride Health, a Boston-based virtual specialty care company built to scale a proven hospital model for treating pediatric anxiety and OCD through insurance. A repeat healthcare entrepreneur who previously founded teledentistry company Virtudent and rose from intern to general manager at athenahealth, he pairs an operator's obsession with measurement with a mission-first conviction that evidence-based care should reach every family that needs it.
Salman Haque is co-CEO of Medsender, the New York healthtech company tearing the fax machine out of American medicine. A Harvard economics grad who cut his teeth in venture and private equity before running operations at the pharmacy startup Capsule, Haque joined Medsender and helped turn a HIPAA-compliant fax tool into an AI workflow platform now used by healthcare providers across all 50 states. Medsender went through Y Combinator's W24 batch, debuted on the Inc. 5000 at #550 in 2025, and raised a $5M Series A led by Ballast Point Ventures.
Saad Alam is the co-founder and CEO of Hone Health, a telehealth platform built around preventative, biomarker-driven longevity care. After a year lost inside the conventional healthcare system, he set out to build the clinic he wished he'd found. Hone now counts hundreds of thousands of tested patients and closed a $33M Series A in early 2025, alongside the acquisition of in-home care company ivee. Before Hone, Alam co-founded the edtech company Citelighter and led market research for Eli Lilly's neuroscience franchise.
Sam Schwager is the co-founder and CEO of SuperDial, a San Francisco voice-AI company that automates the high-volume phone calls between healthcare billing teams and insurance payers. A Stanford computer scientist and former McKinsey consultant, he started the company with college classmate Harrison Caruthers after a personal run-in with out-of-network insurance reimbursement turned into a business. SuperDial raised a $15M Series A led by SignalFire in June 2025 and is taking aim at the roughly $1 trillion the US spends each year on healthcare admin.